Lifeline for DMD boys: expanded access to promising drug vamorolone
Disease control
AVAILABLE
This program offers boys with Duchenne muscular dystrophy (DMD) in the US and Canada continued access to the experimental drug vamorolone after they finish other related studies. The goal is to keep providing treatment while the drug is being reviewed for approval. Participants m…
Sponsor: Santhera Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:55 UTC